Circulars Circular No. 2025-002 2025-03-04 Updates and Amendments to the ASEAN Cosmetic Directive (ACD) as Adopted during the 39th AESAEN Cosmetic Committee (ACC) Meeting and Its Related Meetings Food and Drug Administration · ONAR 25-0259
Circulars FDA Circular No. 2025-001 2025-01-06 Guidelines on the Classification of Vitamins and Minerals for Food/Dietary Supplements for Adults Under Processed Food Product, Repealing the Level Set for Food in the Office Order No. 22, s. 1991, Entitled "Guidelines for the Classification of Vitamins and Minerals as Drug or as Food" Food and Drug Administration · ONAR 25-0067
Memorandum Circulars Memo Circular No. 2024-001 2024-08-05 Validity of License to Operate (LTO) and Certificate of Product Registration (CPR) Granted to Veterinary Establishments and Drug Products for Livestock Feeds Transferred from Bureau of Animal Industry (BAI) to the Food and Drug Administration (FDA) Food and Drug Administration · ONAR 24- 0838
Circulars Circular No. 2024-005 2024-07-03 Updates and Amendments to the ASEAN Cosmetic Directive (ACD) as Adopted during the 38th ASEAN Cosmetic Committee (ACC) Meeting and Its Related Meeting Food and Drug Administration · ONAR 24-0737
Circulars Circular No. 2024-004 2024-05-07 Guidelines on the Issuance of FDA Import Permit as "Samples Only" for Prepackaged Processed Food Products Intended for Research and Development Food and Drug Administration · ONAR 24-0559
Circulars Circular No. 2024-003 2024-03-26 Extension of the Regulatory Flexibility for Class B, C and D Medical Devices Based on FDA Circular No. 2020-001-A entitled "Amendment to Annex A of FDA Circular No. 2020-001 re: Initial Implementation of Administrative Order No. 2018-0002 "Guidelines Governing the Issuance of an Authorization for a Medical Device based on the ASEAN Harmonized Technical Requirements" Food and Drug Administration · ONAR 24-0433
Circulars FDA Circular No. 2023-012 2023-12-29 Recognition of Accredited Technical Service Providers for Radiation Dosimetry of Individual Monitoring Services Food and Drug Administration · ONAR 24-0035
- Circular No. 2023-011 2023-11-21 Updates and Amendments of the ASEAN Cosmetic Directive (ACD) as Adopted during the 37th ASEAN Cosmetic Committee (ACC) Meetingand Its Related Meetings Food and Drug Administration · ONAR 23-1139
Circulars Circular No. 2023-010 2023-10-12 Guidelines on the Conduct of the Food and Drug Administration Trainings and Seminars Offered by the FDA Academy to the External Stakeholders Food and Drug Administration · ONAR 23-1050
Circulars FDA Circular No. 2023-009 2023-09-06 Adoption of 2015 Philippine Dietary Reference Intakes (PDRI) Percent Recommended Energy Intakes/Recommended Nutrient Intakes (%REI/RNI) as the New Dietary Standard of All Prepackaged Processed Food Repealing Bureau Circular No. 16 s. 2005 entitled "Adopting the 2002 Recommended Energy and Nutrient Intakes as the New Dietary Standard" Food and Drug Administration · ONAR 23-0932
Circulars Circular No. 2023-008 2023-08-18 Guidelines on the Publishing of Package Insert and Patient Information Leaflet of Registered Drug Products in the Food and Drug Administration (FDA) Verification Portal System Food and Drug Administration · ONAR 23-1012
Circulars Circular No. 2023-007 2023-04-04 Updates and Amendments of the ASEAN Cosmetic Directive (ACD) as Adopted during the 36th ASEAN Cosmetic Committee (ACC) Meeting and Its Related Meetings Food and Drug Administration · ONAR 23-0392
Circulars Circular No. 2020-033-B 2023-03-31 Addendum to FDA Circular No. 2020-033 "Procedure for the Use of the Modified Electronic Registration System for Raw Materials and Prepackaged Processed Food Products" Repealing FDA Circular No. 2016-014 "Procedure for the Use of Electronic Registration System for Prepackaged Processed Food Products" to Include Process Steps for the Correction of Certificate of Product Registration, Additional Guidelines in Accomplishing Online Application Form, to Include the Requirements Stipulated in FC No. 2021-028, and Express Repeal of Relevant FDA Issuances for this Purpose." Food and Drug Administration · ONAR 23-0392
Circulars Circular No. 2023-006 2023-03-30 Updated Guidelines on the Filing and Submission of Applications for the Licensing and Registration of Household/Urban Hazardous Substances (HUHS) Establishments and Products, Respectively, through the FDA E-Portal V.2 System Food and Drug Administration · ONAR 23-0392
Circulars Circular No. 2021-002-C 2023-03-29 Guidelines on the Regulatory Flexibility for Class B, C and D Medical Devices that are Not Included in the List of Registrable Medical Devices Based on FDA Circular No. 2020-001-A entitled "Amendment to Annex A of FDA Circular No. 2020-001 re: Initial Implementation of Administrative Order No.2018-0002 "Guidelines Governing the Issuance of an Authorization for a Medical Device Based on the ASEAN Harmonized Technical Requirements" Food and Drug Administration · ONAR 23-0392
- Circular No. 2023-005 2023-03-22 Guidelines on the Implementation of the FDA Student Internship Program Food and Drug Administration · ONAR 23-0344
Circulars Circular No. 2023-004 2023-02-17 Guidelines on Regulatory Reliance on the Conduct of Clinical Trials Food and Drug Administration · ONAR 23-0299
Circulars Circular No. 2023- 004 2023-02-17 Guidelines on Regulatory Reliance on the Conduct of Clinical Trials Food and Drug Administration · ONAR 23-0299
Circulars Circular No. 2022-004-A 2023-02-15 Amendment to FDA Circular No. 2022-004 entitled "Implementing Guidelines on the Abridged and Verification Review Pathways for New Drug Registration Applications in accordance with Administrative Order No. 2020-0045 Establishing Facilitated Registration Pathways for Drug Products including Vaccines and Biologicals" to include Generic Drug Registration Applications and update the list of Reference Drug Regulatory Agencies Food and Drug Administration · ONAR 24-00195
- Circular No. 2023-003 2023-02-03 Guidelines on the Filing and Submission of Acceptable Variations on Protocols and Non-Standard Protocols for the Review and Pre-Approval by the Food and Drug Administration Prior to the Conduct of Bio-efficacy Test Studies of Household Pesticides for the Purposes of Securing a Certificate of Product Registration Food and Drug Administration · ONAR 23-0193
